Galsky, M D; Chen, G J; Oh, W K; Bellmunt, J; Roth, B J; Petrioli, R; Dogliotti, L; Dreicer, R; Sonpavde, G (2012). Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma. Annals of oncology, 23(2), pp. 406-10. Oxford: Oxford University Press 10.1093/annonc/mdr156
|
Text
1-s2.0-S0923753419344072-main.pdf - Published Version Available under License Publisher holds Copyright. Download (99kB) | Preview |
Cisplatin-based chemotherapy is a standard treatment of metastatic urothelial carcinoma (UC), though carboplatin-based chemotherapy is frequently substituted due to improved tolerability. Because comparative effectiveness in clinical outcomes of cisplatin- versus carboplatin-based chemotherapy is lacking, a meta-analysis was carried out.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Urology |
UniBE Contributor: |
Roth, Beat |
ISSN: |
0923-7534 |
Publisher: |
Oxford University Press |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:20 |
Last Modified: |
05 Dec 2022 14:05 |
Publisher DOI: |
10.1093/annonc/mdr156 |
PubMed ID: |
21543626 |
Web of Science ID: |
000299744400020 |
BORIS DOI: |
10.48350/6820 |
URI: |
https://boris.unibe.ch/id/eprint/6820 (FactScience: 211850) |
Actions (login required)
 |
Edit item |